Table 1 Characteristics of the study population, N = 133
Mean | SD | |
|---|---|---|
Age (years) | 64.5 | 5.2 |
Revised Framingham Stroke Risk Profile (%) | 3.5 | 2.7 |
Geometric mean | 95% CI | |
Systolic blood pressure (mmHg) | 133.0 | 130.3; 135.8 |
Diastolic blood pressure (mmHg) | 71.6 | 69.9; 73.2 |
BMI (kg/m2) | 27.4 | 26.6; 28.2 |
WHR | 0.8 | 0.8; 0.9 |
Sex hormone binding globulin (nmol/L) | 69.9 | 64.5; 75.8 |
Total cholesterol (mmol/L) | 5.1 | 4.9; 5.3 |
CRP (mg/L) | 1.8 | 1.6; 2.1 |
Progesterone (pg/mL) | 43.0 | 39.3; 47.0 |
17-a-OH-progesterone (pg/mL) | 304.2 | 274.8; 336.8 |
Estrone (pg/mL) | 22.3 | 20.8; 23.9 |
Estradiol (pg/mL) | 4.2 | 3.8; 4.6 |
Testosterone (pg/mL) | 231.5 | 213.3; 251.2 |
DHEA (pg/mL) | 2382.1 | 2151.6; 2637.3 |
Dihydrotestosterone (pg/mL) | 39.8 | 35.8; 44.4 |
Androstenedione (pg/mL) | 560.5 | 519.8; 604.5 |
N | % | |
Type 2 diabetes n (%) | 15 | 11.3 |
Prevalent atrial fibrillation n (%) | 0 | 0 |
Previous CVD n (%) | 8 | 6.0 |
Hypertension n (%) | 38 | 28.6 |